Bionical Emas is the only Contract Research Organization to combine Clinical Development, Clinical Trial Supply and Early Access Programs, enabling us to deliver a unique, seamless approach to bring life-changing medicines to patients around the world.
Full-service CRO, Emas Pharma, was originally established in 1998 to support US pharma companies looking to work across Europe. 11 years later in 2009, Bionical was established as a Clinical Trial Supply business serving the global pharma and biotech industry.
In 2016, the merger of Emas Pharma and Bionical took place, creating the only global Contract Research Organization to combine Clinical Development and Clinical Trial Supply. Then, in 2018, Bionical Emas proudly founded the Early Access Programs division, giving even more of a unique opportunity to help patients around the world gain access to life-changing medicines.
We are now the only CRO to combine Clinical Development, Clinical Trial Supply and Early Access Programs, with a distinctive offering that enables us to maximize access, collect data and evidence generation at every stage of the drug development pathway. We have an established global footprint across the US, EU and Australasia markets and have over 200 employees based around the globe, supporting many thousands of patients.
Our vision is to maximize access and evidence generation across the entire clinical development pathway, positively impacting current and future patients.
Here at Bionical Emas, our outstanding people are driven by their passion for changing patients’ lives. We work together as one team to build long-term partnerships and consistently deliver excellence, whilst pioneering new approaches and being accountable for their success.
We champion a supportive, inclusive and open environment where everyone feels like they belong. We are proud of our people and what they achieve every day by being bold, creative and flexible. Most importantly, we have a lot of fun along the way!
We embrace a holistic approach to quality in every aspect of the company. Our robust processes and Quality Management System complies with international and national regulations and guidelines to enable our teams to deliver services and products to clients and patients around the world.
